Report of Adverse Events in Colombia: A Successful Case

Title:Report of Adverse Events in Colombia: A Successful Case

Volume: 14 Issue: 1

Author(s): Ornella Moreno-Mattar*, Rosana Ramírez, Andrés Alvarado, Francisco Sierra and Javier Guzmán

Affiliation:

• National Food and Drug Surveillance Institute (INVIMA), Carrera 10 # 64, 28 Bogota,Colombia

Keywords: Adverse events, Colombia, electronic report, pharmacovigilance, INVIMA, regional, nodes.

Abstract: Background: The Colombian National Food and Drug Surveillance Institute (INVIMA) is responsible for monitoring the safety and efficacy of medicines circulating the Colombian market.

Discussion: This article summarizes the three key strategies the institution has implemented to strengthen the National Pharmacovigilance Program: improving the interaction and working relationship with regional health authorities, expanding the National Pharmacovigilance Network and implementing the electronic submission of adverse events.

Conclusion: The number of adverse events reported in Colombia increased from 5,447 in 2013 to 95,658 in 2017, reaching a population-based reporting ratio within international standards (563 in 2016).

Cite this article as:

Moreno-Mattar Ornella *, Ramírez Rosana , Alvarado Andrés, Sierra Francisco and Guzmán Javier , Report of Adverse Events in Colombia: A Successful Case, Current Drug Safety 2019; 14 (1) . https://dx.doi.org/10.2174/1574886313666181109150648